Managing Respiratory Conditions with Elipta and Prednisone

Clinical Context for Combined Use

• For acute asthma exacerbations not controlled with inhaled corticosteroids alone, adding systemic prednisone at 40-60 mg/day is appropriate and necessary to induce remission 1
• Prednisone should generally be used for short-term therapy (typically 5-10 days for acute exacerbations) to minimize adverse effects 1

Important Safety Considerations

HPA Axis Suppression Risk

• The combination of oral and inhaled corticosteroids increases the risk of hypothalamic-pituitary-adrenal (HPA) axis suppression and adrenal insufficiency 1
• This risk is cumulative and increases with both dose and duration of combined therapy 1

Vaccination Timing

• Vaccination may be postponed for patients receiving >20 mg of prednisone 2
• Inactivated vaccines (influenza, pneumococcal) should be deferred in patients unlikely to respond, including those on high-dose corticosteroids 2
• Live vaccines are contraindicated during immunosuppressive therapy 2

Infection Risk

• The combination may have additive immunosuppressive effects, requiring vigilance for opportunistic infections 2

Practical Management Algorithm

For Acute Exacerbations:

• Add prednisone 40-60 mg daily for 5-10 days while continuing Elipta 1
• Evaluate patient response between 2-4 weeks to determine if therapy modifications are needed 1

For Longer-Term Combined Therapy:

• If corticosteroid therapy is needed beyond acute treatment, taper prednisone over 6-8 weeks 1
• Avoid prolonging oral corticosteroid use beyond what is necessary, as systemic effects accumulate with duration and dose 1

Dosing Optimization:

• Schedule prednisone doses in the morning to minimize sleep disturbances and align with natural cortisol rhythm 1

Common Pitfalls to Avoid

• Do not abruptly discontinue prednisone after prolonged use (>2-3 weeks), as this can precipitate adrenal crisis due to HPA axis suppression 1
• Do not assume all patients need stress-dose steroids for procedures: avoid stress-dose steroids for vaginal delivery, but do provide them for cesarean delivery 1

Monitoring Recommendations

• Assess clinical response within 2-4 weeks of initiating combined therapy 1
• Evaluate for corticosteroid-related side effects including hyperglycemia, hypertension, and mood changes, which are more common with systemic than inhaled corticosteroids 3